Improved Mg2+-based reverse transcriptase assay for detection of primate retroviruses.

Area of Science:

• Virology
• Biochemistry
• Molecular Biology

Background:

• Reverse transcriptase (RT) assays detect retroviruses based on enzyme activity.
• Existing assays require standardization for clinical and biological sample analysis.
• Primate retroviruses, such as type E and D, pose potential human health risks.

Purpose of the Study:

• To develop and standardize a novel 32P-based RT assay.
• To determine the sensitivity, reproducibility, and specificity of the improved assay.
• To detect pathogenic primate retroviruses relevant to human health.

Main Methods:

• A 32P-based, Mg2+-dependent reverse transcriptase assay was developed.
• The assay was tested for sensitivity using human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIVmac).
• Detection of genetically distinct type D retroviruses was also evaluated.

Main Results:

• The assay demonstrated high sensitivity: <3.2 50% tissue culture infective doses (TCID50s) for HIV-1 and <1 TCID50 for SIVmac.
• Detection of 10(-5) U of recombinant HIV-1 RT enzyme (equivalent to 4.25 x 10(4) virions) was achieved.
• Genetically diverse type D retroviruses, including simian AIDS retrovirus and squirrel monkey retrovirus, were successfully detected.

Conclusions:

• The improved RT assay effectively detects genetically divergent, Mg2+-dependent retroviruses of human and simian origin.
• This assay is suitable for analyzing biological products and clinical samples for retroviral contamination.
• The assay's ability to detect potentially pathogenic primate retroviruses enhances human health surveillance.